Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Wipro unveils Lab45 AI platform to transform business functions with Generative AI Wipro Limited, a global leader in technology services and consulting, has launched the Lab45 Artificial Intelligence (AI) Platform.… byPallavi MadhirajuJune 11, 2024